The University of Texas MD Anderson Cancer Center today celebrated a milestone in the construction of its three-story clinic in The Woodlands, a facility due to open to patients in spring 2019. The “topping out” signals the placement of the final structural beam in the 208,000-square-foot building located at the corner of State Highway 242 and Fellowship Dr. When completed next year, the outpatient clinic will house treatment and supportive...
The University of Texas MD Anderson Cancer Center and RaySearch Laboratories today announced a strategic alliance with the aim of enhancing...
The University of Texas MD Anderson Cancer Center was awarded $22.3 million from the Cancer Prevention and Research Institute of Texas...
Three simultaneous safety and efficacy studies of the drug larotrectinib reported an overall response rate of 75 percent for patients ages four months to 76 years with 17 different cancer diagnoses. All patients had tumors with tropomyosin receptor kinase (TRK) fusions, gene mutations that switch on TRK genes, allowing cancer growth. The studies indicate larotrectinib as a potentially powerful new treatment approach for the approximately...
Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a normal...
A common cold virus engineered to attack the most common and deadly of brain tumors allowed 20 percent of patients with recurrent glioblastoma...
Triple-negative breast cancer (TNBC), a highly aggressive, relapse-prone cancer that accounts for one-fourth of all breast cancers, could...
The University of Texas MD Anderson Cancer Center and its 20,000 faculty and staff devoted exclusively to patient care, research, education...